mouse anti-te7 (Millipore)
90
Structured Review
Millipore
mouse anti-te7
Mouse Anti Te7, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-te7/te+7+antibody/us11789011-699-42-45
Average 90 stars, based on 1 article reviews
Mouse Anti Te7, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mouse+anti-te7/te+7+antibody/us11789011-699-42-45
Average 90 stars, based on 1 article reviews
mouse anti-te7 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Saline:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Incubation:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Immunostaining:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Marker:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Expressing:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Blocking Assay:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Staining:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Transduction:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: Triple Immunostaining:Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: For IF with the following antibodies: rabbit anti-Sox2 (1:100; D6D9, Cell Signaling Technology), mouse anti-Nanog (1:200; ab173368, Abcam), rabbit anti-vimentin (1:200; D21H3, Cell Signaling Technology), and Article Title: Engineered three-dimensional breast tissue, adipose tissue, and tumor disease model Article Snippet: Slides were then blocked with 10% goat serum in Tris-buffered saline (TBS) for 1 hour, followed by incubation with primary antibodies overnight at 4° C. The following primary antibodies were utilized: mouse anti-cytokeratin 8 (1:100; Abcam, Cambridge, Mass.); rabbit anti-CD31 (1:100; Abcam); Article Title: Direct Neuronal Reprogramming for Disease Modeling Studies Using Patient-Derived Neurons: What Have We Learned? Article Snippet: The following primary antibodies were used in the blocking solution overnight at 4°C: chicken anti-MAP2 (1:15,000; Abcam, ab5392); mouse anti-TUJ1 (1:1,000; Promega, G7121); rabbit anti-TUJ1 (1:1,000; BioLegend, 801201); Article Title: The combination of glycosaminoglycans and fibrous proteins improves cell proliferation and early differentiation of bovine primary skeletal muscle cells. Article Snippet: Mouse anti-TE7 and Article Title: Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues Article Snippet: |